Selecting a single cell from a heterogeneous transfection pool that will scale-up appropriately from a micro-scale system to a commercial facility is a challenging and hugely important task. This clonal cell line needs to demonstrate the desired product quality attributes and ensure manufacturability throughout the entire drug manufacturing lifecycle. This process typically requires 6 to 12 months and is a time, capital and labour intensive process. High throughput (HT) methodologies are increasingly being adopted to speed up this cell line selection protocol. However, often the large quantities of data generated in combination with the increase in availability of analytics results in a daunting multivariate data analysis problem. Typically...
Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2019, In conjunct...
The industry's pursuit for higher antibody production has led to increased cell density cultures tha...
Biopharmaceutical therapeutic development timelines can be reduced by quickly generating material to...
The timelines for cell line development and early-stage process development are decreasing, but simu...
Cell line development for manufacturing is a lengthy, multi-step, resource intensive, critical path ...
In the biopharmaceutical industry, the selection of high-quality cell lines characterized by high pr...
Early development datasets are typically unstructured, incomplete and truncated, yet they are readil...
Early development datasets are typically unstructured, incomplete and truncated, yet they are readil...
The scale up/down of biopharmaceutical processes is still a very challenging task. Different cell li...
In this talk we will present how we accelerated a clone selection process by 4 weeks while increasin...
Rapid increase in the demand for biopharmaceutical products has posed a challenge in the selection o...
The provision of stably expressing, high-yield mammalian cell lines is a key step in bioprocess deve...
The development of a successful biologic therapeutic manufacturing process begins with the creation ...
The development of biopharmaceutical therapeutics, such as monoclonal antibodies, requires the testi...
The development of biopharmaceutical therapeutics, such as monoclonal antibodies, requires the testi...
Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2019, In conjunct...
The industry's pursuit for higher antibody production has led to increased cell density cultures tha...
Biopharmaceutical therapeutic development timelines can be reduced by quickly generating material to...
The timelines for cell line development and early-stage process development are decreasing, but simu...
Cell line development for manufacturing is a lengthy, multi-step, resource intensive, critical path ...
In the biopharmaceutical industry, the selection of high-quality cell lines characterized by high pr...
Early development datasets are typically unstructured, incomplete and truncated, yet they are readil...
Early development datasets are typically unstructured, incomplete and truncated, yet they are readil...
The scale up/down of biopharmaceutical processes is still a very challenging task. Different cell li...
In this talk we will present how we accelerated a clone selection process by 4 weeks while increasin...
Rapid increase in the demand for biopharmaceutical products has posed a challenge in the selection o...
The provision of stably expressing, high-yield mammalian cell lines is a key step in bioprocess deve...
The development of a successful biologic therapeutic manufacturing process begins with the creation ...
The development of biopharmaceutical therapeutics, such as monoclonal antibodies, requires the testi...
The development of biopharmaceutical therapeutics, such as monoclonal antibodies, requires the testi...
Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2019, In conjunct...
The industry's pursuit for higher antibody production has led to increased cell density cultures tha...
Biopharmaceutical therapeutic development timelines can be reduced by quickly generating material to...